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Embryonic day (E) 28 (E28) pig pancreatic primordia trans-
planted into the mesentery of non-immunosuppresed steptozotocin 
(STZ)-diabetic Lewis rats normalize levels of circulating glucose 
within 2–4 weeks. Exocrine tissue does not differentiate after trans-
plantation of pancreatic primordia. Rather individual endocrine 
(beta) cells engraft within the mesentery.
To determine whether transplanted pig pancreatic primordia 
engraft, differentiate and function in rat hosts after preservation in 
vitro, we implanted pig pancreatic primordia into STZ-diabetic rats 
either directly or after 24 hours of suspension in ice-cold University 
of Wisconsin (UW) preservation solution with added growth 
factors. Here we show engraftment in mesentery and mesenteric 
lymph nodes and normalization of glucose levels in STZ-diabetic 
rat hosts following transplantation of preserved E28 pig pancreatic 
primordia comparable to glucose normalization after transplanta-
tion of non-preserved E28 pancreatic primordia.
Introduction
One strategy to overcome the limited potential for growth/
division of mature islet cells is to transplant fetal pancreatic tissues 
(pancreatic primordia) that have a capacity for beta cell expan-
sion post-implantation.1,2 Their potential for expansion sufficient 
to render a diabetic host euglycemic is reflected by normaliza-
tion of glucose levels in a diabetic rat post-transplantation of a 
single primordium.3 To establish the feasibility of pig-to-rodent 
xenotransplantation of pancreatic primordia, we implanted pancre-
atic primordia from embryonic day (E) 28 (E28) pig embryos 
into streptozotocin-diabetic adult Lewis rats. Remarkably if trans-
planted within a developmental ‘window’ prior to E35 (E28 works 
best), pig pancreatic primordia engraft post-implantation into 
non-immunosuppressed immunocompetent diabetic rat hosts.4,5 
Glucose tolerance in streptozotocin-diabetes in rats is normal-
ized permanently by the physiological secretion of porcine insulin 
from transplanted pig pancreatic primordia.5 We have shown that 
glucose tolerance can be normalized post-transplantation of E28 
pig pancreatic primordia into non-immunosuppressed ZDF rats, a 
model for insulin-resistant type 2 diabetes in humans.6 Recently we 
have shown that E28 pig pancreatic primordia engraft long-term 
(~2 years) in mesenteric lymph nodes following transplantation into 
the mesentery of STZ-diabetic rhesus macaques. Exogenous insulin 
requirements are reduced significantly within four weeks after trans-
plantation of primordia. Following transplantation porcine insulin, 
but not rhesus macaque insulin can be detected in circulation. These 
data support potential clinical applicability for transplantation of pig 
pancreatic primordia into diabetic humans.7
Theoretically, if employed for clinical use in humans, pancreatic 
primordia could be harvested immediately prior to implantation. 
However, practically it would be best if pancreatic primordia could 
be stored in vitro for a period of time prior to transplantation. To 
determine whether E28 pig pancreatic primordia can be stored in 
vitro prior to transplantation, we transplanted pancreatic primordia 
from E28 pig embryos into the mesentery of non-immunosup-
pressed streptozotocin-diabetic (host) rats either directly or after 24 
hours of preservation in vitro. Here we show that preserved E28 
pig pancreatic primordia engraft and normalize levels of glucose in 
STZ-diabetic rat hosts.
Results
We compared levels of glucose in each of four groups of rats: 
(1) Control, non-diabetic rats (n = 4); (2) Non-immunosuppressed 
diabetic Lewis rats into which five E28 pig pancreatic primordia 
were transplanted within 45 minutes of isolation (TX) (n = 4); 
(3) Non-immunosuppressed diabetic Lewis rats that underwent sham 
surgery (Diabetic) ( n = 4); or (4) Non-immunosuppressed diabetic 
Lewis rats into which five E28 pig pancreatic primordia that had been 
preserved in vitro for 24 hours were transplanted (TX PRESERVED) 
(n = 3).
Following administration of streptozotocin and prior to trans-
plantation or sham surgery (Week 0) rats in Diabetes; TX and 
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TX-PRESERVED groups were grossly hyperglycemic. In contrast, 
on weeks 4–6, glucose levels were no different between rats in the 
control group (Control); rats into which five E28 pig pancreatic 
primordia had been transplanted 4–6 weeks before (TX); or rats 
into which five preserved E28 pig pancreatic primordia had been 
transplanted 4–6 weeks before (TX PRESERVED). As before,4 
levels of glucose were not reduced post-sham transplantation 
(Fig. 1). We have shown previously that levels of glucose are normal-
ized for as long as 20 months post-transplantation of E28 pig 
pancreatic primordia into formerly diabetic rats.5 At one year post-
transplantation, levels of glucose in the TX-PRESERVED group were 
105 ± 4 mg/dl (n = 3), no different than levels in the four control 
rats (121 ± 5 mg/dl). Three of the four sham-operated (Diabetic) rats 
did not survive one year. One was dead by 14 weeks post-surgery 
(glucose measured at 12 weeks was 316 mg/dl). The second was 
dead by 21 weeks post-surgery (glucose measured at 20 weeks was 
228 mg/dl). The third was dead by 41 weeks post-surgery (glucose 
measured at 40 weeks was 550 mg/dl). The survivor was hypergly-
cemic at 52 weeks post-sham surgery (glucose was 434 mg/dl).
Shown in Figure 2 are tissue sections from formerly diabetic rats 
into which preserved pig pancreatic primordia had been transplanted 
one year previously. Cells expressing porcine proinsulin mRNA that 
stain with use of the antisense probe (Fig. 2B, D, F and H), but 
not the sense probe (Fig. 2A, C, E and G) are present in medul-
lary sinus of mesenteric lymph nodes (Fig. 2A–F) and in mesentery 
(Fig. 2G and H). Rare porcine-proinsulin expressing cells are detect-
able in liver (not shown). Kidney, pancreas and spleen are negative 
for porcine proinsulin-expressing cells.
Cells in medullary sinus of mesenteric lymph nodes and mesen-
tery that stain positive for insulin are shown in Figure 3. Sections B 
and D show insulin-positive cells (red). Control stains are shown in 
Figure 3A and C.
Discussion
The insufficient supply of tissue, loss post-transplantation and 
limited potential for expansion of beta cells restricts the utility of 
islet allotransplantation.9 A way to address the supply problem is 
to transplant pig tissue.10 A theoretical way to overcome the expan-
sion problem is to transplant embryonic pancreas that can undergo 
expansion in situ.1,2
In previous studies, we implanted whole E12.5 Lewis rat pancre-
atic primordia4,11 or E28-29 Yorkshire pig pancreatic primordia4,5 
into the mesentery of adult streptozotocin-diabetic Lewis rats. 
Control of diabetes is achieved within 2–4 weeks following trans-
plantation and the abnormal pattern of weight gain in diabetic 
animals restored to normal post-transplantation. Consistent with 
the findings of others,1-3 exocrine tissue does not differentiate. 
Rather, following isotransplantation in rats, the pancreatic primordia 
differentiate into novel structures consisting of islets surrounded by 
stroma.4,11 Rather than islets surrounded by stroma, only isolated 
endocrine cells engraft within the rat mesentery at 20 weeks post-
xenotransplantation of E28 or E29 pig pancreatic primordia.4,5 If 
obtained from E28 or E29 embryos pig pancreatic primordia engraft 
post-implantation into STZ diabetic Lewis rat hosts without the need 
for immunosuppression. In contrast, pancreatic primordia obtained 
from E35 embryos are rejected and glucose levels remain elevated.5 
E28 pig pancreatic primordia engraft long-term in non-immunosup-
pressed diabetic non-human primates (rhesus macaques) and reduce 
exogenous insulin requirements consistent with a potential for their 
use in diabetic humans.7 Although diabetes was not ‘cured’ in our 
rhesus macaques, it is possible that insulin requirements post-trans-
plantation can be reduced further by transplanting more tissue at a 
given time or by repetitive transplantation or by enhancing beta cell 
Figure 1. Levels of glucose in non-diabetic (Control) rats (n = 4) and in 
streptozotocin-diabetic rats into which 5 E28 pig pancreatic primordia had 
been transplanted (TX) (n = 4); or in which sham surgery was performed 
(Diabetic) (n = 4) or into which 5 E28 pig pancreatic primordia that had 
been preserved in vitro for 24 hours had been transplanted (TX PRESERVED) 
(n = 3); following measurement of glucose at week 0. Data are expressed 
as mean ± standard error of the mean.
Figure 2. (A–F) Mesenteric lymph nodes (G and H) Mesentery originating 
from diabetic Lewis rats into which preserved E28 pig pancreatic primor-
dia had been transplanted one year previously: In situ hybridization was 
performed using pig proinsulin sense (A, C, E and G) or antisense (B, D, F 
and H) probes. Arrow delineates medullary sinus in A and B. Arrowhead 
designates cells that stain positive for porcine proinsulin mRNA (D, F and H) 
and a negative-staining cell with similar morphology (E). Magnifications are 
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growth in vivo after transplantation. Future studies will be necessary 
to explore such possibilities in order that normalization of glucose 
tolerance in hosts reaches a threshold for clinical application.
While data generated in rhesus macaques will provide insight into 
the numbers of pig pancreatic primordia that might be required to 
correct diabetes in a human, and the time it will take post-transplan-
tation for the primordia to produce sufficient insulin to render hosts 
euglycemic, only studies in humans, if and when conducted, can 
provide definitive answers to these questions.
In the case of human allotransplantation, there is an unavoid-
able delay between the time of harvest from donors and the time of 
implantation into recipients. Prior to removal from the donor, 
human renal allografts are flushed with a preservation solution, often 
University of Wisconsin (UW) solution, and stored subsequently 
in ice-cold UW solution.8,12 Theoretically, pancreatic primordia 
used for transplantation could be harvested immediately prior to 
implantation. However, practically it would be best if, like most 
grafts, pancreatic primordia could be stored in vitro for a period 
of time prior to transplantation. The ability to store pancreatic 
primordia would permit their distribution to sites for transplanta-
tion, distant from the site of harvesting and would allow time to plan 
the transplant procedure. Here (Figs. 1–3) we demonstrate viability, 
as evidenced by normalization of glucose and engraftment in hosts, 
for preserved E28 pig pancreatic primordia transplanted into rats. 
Preservation for 24 hours appears to have no detrimental effects 
whatsoever.
Transplantation of embryonic pancreas to replace the function of 
a diseased organ1-7,11,13 (organogenesis of the endocrine pancreas) 
offers theoretical advantages relative to transplantation of either 
embryonic stem (ES) cells, or of fully differentiated (adult) pancreas 
or islets from adults or neonatal animals. Thus: (1) Unlike ES cells, 
pancreatic primordia obtained at the proper time during embryogen-
esis differentiate along defined organ committed lines. There is no 
requirement to steer differentiation and no risk of teratoma forma-
tion;13 (2) The growth potential of cells within embryonic pancreas 
is enhanced relative to those in terminally-differentiated adult 
pancreas or adult islets in that it is possible to restore glucose toler-
ance in a diabetic rat by transplanting a single pancreatic primordium 
within 2–4 weeks.3 Neonatal pig islets transplanted into pancre-
atectomized immunosuppressed pigs normalize levels of glucose 
within a comparable time period post-transplantation (14 days).14 
(3) Only endocrine tissue differentiates following  transplantation 
of pancreatic primordia obtained sufficiently early during embryo-
genesis1-7,11 obviating problems of host tissue digestion by exocrine 
pancreatic components;3 and (4) The cellular immune response to 
transplanted embryonic pancreas obtained early during embryogen-
esis is attenuated relative to that directed against organs obtained at 
later times.15
During normal pancreatic organogenesis, individual endocrine 
cells first migrate away from primitive ducts prior to coalescing 
into islets. Migration and coalescence are guided by cell adhesion 
molecules.16 We speculate that the failure of individual pig endocrine 
cells to coalesce into islets post-transplantation of E28 pig pancreatic 
primordia into rats4-6 or non-human primates,7 may result from the 
absence of adhesion molecules in rat4-6 or primate7 interstitium that 
are recognized by pig endocrine cells. In contrast rat endocrine cells 
recognize mouse adhesion molecules.11 One explanation for our 
ability to transplant E28 pig pancreatic primordia without immuno-
suppression into rats or rhesus macaques may be that the absence of 
both exocrine tissue and islets results in a pattern of antigen expres-
sion that is not recognized as foreign by the host.6,7 An alternative 
explanation is host tolerance on the basis of microchimerism or 
mixed chimerism as proposed by Abraham et al., to explain successful 
xenoengraftment of human pancreatic islet-derived progenitor cells 
in multiple tissues of non- immunosuppressed immunocompetent 
mice.17 Another is ‘T cell paralysis’18 on the basis host exposure to 
antigen plus SLA II that is expressed on pig beta cells19,20 in the 
absence of second costimulatory signal.
Neural cell adhesion molecule (NCAM) is an important regular 
of endocrine cell aggregation during islet development.21 Crnic et al. 
showed that loss of NCAM function causes the formation of lymph 
node metastasis in a transgenic model of pancreatic beta cell carcinogen-
esis (Rip1Tag2). Metastases were facilitated by upregulated pancreatic 
lymphangiogenesis possibly induced by disaggregation of endocrine 
cells.22 It may be that failure of endocrine cells to aggregate following 
transplantation of E28 pig pancreatic primordia in the mesentery of 
rats4-6 or rhesus macaques7 induces a comparable lymphagiogenesis 
that permits migration of beta cells to regional lymph nodes.
Methods
Isolation and transplantation of pancreatic primordia. Animal 
care followed Institutional Animal Care and Use Committee 
(IACUC) standards. At 28 days gestation, pregnant Yorkshire pigs 
(Oak Hill Genetics, Ewing IL) were intubated and anesthesia main-
tained by inhalation of isoflurane and O2 to effect. The uterus was 
removed and the donor pig was then euthanized.4-6
Pancreatic primordia from E28 pig embryos were surgically isolated 
under a dissecting microscope.4-6 After isolation, primordia were 
placed immediately into ice-cold Dulbecco’s modified Eagles Medium: 
Hams F12 (DMEM:HF12) containing iron-saturated transferrin 
(5 mg/ml), 25 nM prostaglandin E1 and, 5 mg/ml rhVEGF 
(Genentech Inc.) and 10-8 M rhHGF (Upstate Biotechnology, 
Lake Placid NY). After 45 minutes, five pancreatic primordia were 
implanted between layers of mesentery of 6–10 week old diabetic 
Lewis rat hosts in close proximity to blood vessels.4-6 Host rats received 
no immunosuppression. Other E28 primordia were suspended in 1 ml 
Figure 3. Photomicrographs of (A and B) rat mesenteric lymph nodes; 
(C and D) rat mesentery 1 year post-transplantation of preserved E28 pig 
pancreatic primordia. (A and C) Control serum-stained sections; (B and D) 
Anti-insulin antibody-stained sections. Arrowheads delineate endocrine cells 



















ice-cold University of Wisconsin (UW) solution (ViaSpan, DuPont 
Pharmaceuticals) containing 10 -9 M HGF; 10-9 M IGF I and 1 mg/
ml VEGF and stored for 24 hours at 4°C prior to transplantation. 
The growth factors and concentrations of growth factors added to the 
UW solution were chosen on the basis of our successful use of such a 
solution (UW + growth factors) to preserve renal primordia prior to 
transplantation into the mesentery of rats with reduced renal func-
tion.8 The composition of the UW solution differs in growth factor 
content from the ice-cold DMEM:HF12 in which non-preserved 
pancreatic primordia were suspended prior to implantation in this 
study and in previous studies.4-6 Other diabetic rats underwent sham 
surgery during which no primordia were implanted. Concurrently, 
other control rats were not rendered diabetic.
Measurement of glucose. Levels of glucose were measured using 
the Roche Diagnostic System/COBAS (Roche Diagnostic Systems, 
Somerville, NJ) in serum obtained (via tail vein) at 8 AM after an 
overnight fast.
Histology. At one year post-transplantation, tissue was removed 
from hosts. Tissues were fixed in 10% phosphate-buffered Formalin. 
The fixative was removed, tissues embedded in paraffin, sliced into 
5 mm sections and placed on glass slides in preparation for staining. 
Polyclonal rabbit anti-insulin antiserum was obtained from Accurate 
Chemicals (Westbury NY). Normal rabbit serum was substituted for 
the anti-serum in control stains. Sections were counterstained using 
hematoxylin.
Induction of diabetes mellitus and treatment with exogenous 
insulin. Diabetes mellitus was induced in rats by a single intra-
peritoneal injection of 65 mg/kg streptozotocin five days prior to 
transplantation of pancreatic anlagen. The diabetogenic response to 
streptozotocin varied from rat to rat. Rats were considered diabetic 
if their fasting blood glucose level was 225 mg/dl or above five days 
after streptozotocin administration, at which time pig pancreatic 
primordia were implanted. Maintenance of glucose levels below 
200 mg/dl during the first 2–3 weeks post-transplantation is neces-
sary to permit optimal differentiation, proliferation and function of 
transplanted E28 pig pancreatic primordia. Accordingly, rats trans-
planted with pig pancreatic primordia were treated with Humulin 
U ultralente insulin (Eli Lilly Indianapolis IN) for 2–3 weeks after 
implantation (1–4 units s.q bid) to keep levels of fasting glucose, 
measured every 3 days, at approximately 200 mg/dl. Administration 
of exogenous insulin was stopped in all rats after three weeks.5
Detection of insulin transcripts using in-situ hybridization. In 
situ hybridization was performed on sliced 5 mm paraffin-embedded 
sliced tissue sections using a kit from GeneDetection (Bradenton 
FL) exactly as per the manufacturer’s instructions (1 June 2001, 
Version 1.20). Sections were permeabilized with proteinase K 
[DAKO Cytomation Inc (Capinteria CA)]. We used mRNA In situ 
Hybridization Solution (DAKO) as pre-hybridization and hybrid-
ization buffer. We used horseradish peroxidase-mediated detection 
with Tyramide Signal Amplification [NEN/PerkinElmer (Wellesley 
MA) TSA Biotin System Catalog#NEL700]. Digoxin-labeled anti-
sense probes (GeneDetection), that detect porcine, but not rat 
transcripts6 were complementary to nucleotides 230–264 of porcine 
preproinsulin cDNA: 5'-GGCGGAGAACCCTCAGGCAGGTGC-
CGTGGAGCTGG-3' (Genbank: AY044828). All probes were 
labeled unless otherwise noted. A sense probe was used for control 
stains.
Acknowledgements
Supported by George M. O’Brien Center DK079333 and grant 
1-2005-110 from J.D.R.F.
References
 1. Hegre OD, Leonard RJ, Erlandsen SL, McEvoy RC, Parsons RP, Lazarow A. Transplantation 
of islet tissue in the rat Acta Endocrinologia 1976;205:257-78.
 2. Brown J, Clark WR, Molnar IG, Mullen YS. Fetal pancreas transplantation for reversal of 
streptozotocin-induced diabetes in rats. Diabetes 1976; 25:56-64.
 3. Brown J, Heninger D, Kuret J, Mullen YS. Islet cells grow after transplantation of fetal 
pancreas and control of diabetes. Diabetes 1981; 30:9-13.
 4. Rogers SA, Chen F, Talcott M, Hammerman MR. Islet cell engraftment and control of 
diabetes in rats following transplantation of pig pancreatic anlagen. Am J Physiol 2004; 
286:502-9.
 5. Rogers SA, Liapis H, Hammerman MR. Normalization of glucose post-transplantation 
of pig pancreatic anlagen into non-immunosuppressed diabetic rats depends on obtaining 
anlagen prior to embryonic day 35. Transplant Immunology 2005; 14:67-75.
 6. Rogers SA, Chen F, Talcott M, Liapis H, Hammerman MR. Glucose tolerance normaliza-
tion following transplantation of pig pancreatic primordia into non-immunosuppressed 
diabetic ZDF rats. Transplant Immunology 2006; 16:176-84.
 7. Rogers SA, Thomas JM, Chen F, Talcott MR, Faulkner C, Thomas JM, Thevis M, 
Hammerman MR. Long-term engraftment following transplantation of pig pancreatic pri-
mordia into non-immunosuppressed diabetic rhesus macaques Xenotransplantation 2007; 
14:591-602.
 8. Rogers SA, Hammerman MR. Transplantation of metanephroi after preservation in vitro. 
Am J Physiol 2001; 281:661-5.
 9. Bottino R Trucco M. Multifaceted therapeutic approaches for a multigenic disease. Diabetes 
2005;54:79-86.
 10. Sachs DH. The pig as a potential xenograft donor. Veterinary Immunology and 
Immunopathology 1994; 43:185-91.
 11. Rogers SA, Liapis H, Hammerman MR. Intraperitoneal transplantation of pancreatic anla-
gen ASAIO Journal 2003; 49:527-32.
 12. Danovitch GM, Cohen DJ, Weir MR, Stock RG, Bennett WM, Christiansen LL, Sung RS. 
Current status of kidney and pancreas transplantation in the United States 1994-2003. Am 
J Transplantation 2005;5:904-15.
 13. Eventov Friedman S, Katchman H, Shezen E, Arnivich A, Tchorsh D, Dekel B. Freud E, 
Reisner Y. Embryonic pig liver, pancreas and lung as a source for transplantation: Optimal 
organogenesis without teratoma depends on distinct time windows. Proc Natl Acad Sci USA 
2005; 102:2928-33.
 14. Kin T, Korbutt GS, Kobayashi T, Dufour JM, Rajotte RV. Reversal of diabetes in pancre-
atectomized pigs after transplantation of neonatal porcine islets Diabetes 2005; 54:1032-9.
 15. Eventov-Friedman S, Tchorsh D, Katchman H, Shezan E, Arnovich A, Hecht G, Dekel B, 
Rechavi G, Blazar B, Feine I, Tal O, Freud E, Reisner Y. Embryonic pig pancreatic tissue 
transplantation for the treatment of diabetes. PLoS Medicine 2006; 7:1165-77.
 16. Kim SK, Hebrok M. Intercellular signals regulating pancreas development and function. 
Genes & Development 2001; 15:111-27.
 17. Abraham EJ, Kodama S, Lin JC, Ubeda M, Faustman DL, Habener JF. Human pancreatic 
islet-derived progenitor cell engraftment in immunocompetent mice. Am J Pathology 2004; 
164:817-30.
 18. Burkley LC, Lo D, Flavell RA. Tolerance in transgenic mice expressing major histocompat-
ibility molecules extrathymically on pancreatic cells. Science 248:1364-8.
 19. Murray AG, Nelson RC, Rayat GR, Eliott JF, Korbutt GS. Neonatal porcine islet cells 
induce human CD4+ but not CD 8+ lymphocyte proliferation and resist cell-mediated 
cytolytic injury in vitro. Diabetes 1999; 48:1713-9.
 20. Edamura K, Nasu K, Nishimura R, Ogawa H, Sasaki N, Ohgawara H. Effect of long-term 
culture on the expression of antigens and adhesion molecule in single porcine pancreatic 
endocrine cells. Xenotransplantation 2005; 12:327-32.
 21. Cirulli V, Bettens D, Rutihauser U, Halban PA, Orci L, Roullier DG. Expression of neural 
cell adhesion molecule (N-CAM) in rat islets and its role in islet type segregation J. Cell 
Science 1994; 107:1429-36.
 22. Crnic I, Strittmatter K, Cavalerro U, Kopfstein L, Jussila L, Alitaloi K, Christorori G. Loss 
of neural cell adhesion molecule induces tumor metastasis by upregulating lymphangiogen-
esis. Cancer Res 2004; 64:8630-8.
